Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell Lymphoma [Phase 2]

View source ↗

Summary

This clinical trial update notes the completion of a Phase 2 study evaluating Adeno-IFN Gamma for cutaneous B-cell lymphoma, focusing on safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous B-cell Lymphoma

Drugs mentioned

• Adeno-IFN Gamma

Snippet

Sponsor: Transgene | Conditions: Lymphoma, B-Cell | Phase 2 | Status: COMPLETED